Free Trial

Itron, Inc. (NASDAQ:ITRI) Given Average Recommendation of "Moderate Buy" by Brokerages

Itron logo with Computer and Technology background

Key Points

  • Itron, Inc. has received an average recommendation of "Moderate Buy" from thirteen analysts, with the average 1-year price target set at $138.10.
  • The company's recent earnings report for Q2 showed an EPS of $1.62, exceeding consensus estimates, although revenue fell slightly short of expectations.
  • Insider trading activities included the sale of shares by senior vice presidents, with a total of 3,037 shares sold over the last quarter, indicating a 1.51% insider ownership post-transactions.
  • Five stocks to consider instead of Itron.

Shares of Itron, Inc. (NASDAQ:ITRI - Get Free Report) have been assigned an average rating of "Moderate Buy" from the thirteen analysts that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation, ten have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $138.10.

Several equities analysts have recently weighed in on the company. Zacks Research upgraded Itron from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, October 14th. Weiss Ratings reissued a "buy (b)" rating on shares of Itron in a research note on Wednesday, October 8th. Stephens restated an "equal weight" rating and issued a $130.00 price objective on shares of Itron in a report on Tuesday, October 7th. Roth Capital increased their target price on shares of Itron from $130.00 to $150.00 and gave the company a "buy" rating in a research report on Tuesday, July 22nd. Finally, Johnson Rice downgraded shares of Itron from a "buy" rating to an "accumulate" rating in a research note on Friday, August 1st.

Read Our Latest Stock Analysis on Itron

Itron Stock Performance

ITRI opened at $133.66 on Wednesday. The firm's fifty day simple moving average is $124.43 and its two-hundred day simple moving average is $121.26. Itron has a 52-week low of $90.11 and a 52-week high of $140.04. The company has a market cap of $6.11 billion, a price-to-earnings ratio of 22.85, a PEG ratio of 0.74 and a beta of 1.48. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48.

Itron (NASDAQ:ITRI - Get Free Report) last released its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.29. The business had revenue of $606.76 million during the quarter, compared to analysts' expectations of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. The company's quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.21 earnings per share. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Equities analysts anticipate that Itron will post 5.33 earnings per share for the current fiscal year.

Insider Buying and Selling at Itron

In other Itron news, SVP Donald L. Reeves III sold 547 shares of the business's stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $68,544.57. Following the transaction, the senior vice president owned 19,604 shares of the company's stock, valued at approximately $2,456,577.24. The trade was a 2.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Justin K. Patrick sold 388 shares of the company's stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $48,620.28. Following the completion of the sale, the senior vice president owned 20,761 shares of the company's stock, valued at approximately $2,601,560.91. The trade was a 1.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 3,037 shares of company stock worth $380,566. 1.51% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Twin Peaks Wealth Advisors LLC acquired a new stake in Itron during the second quarter worth about $30,000. Bessemer Group Inc. grew its stake in shares of Itron by 125.7% in the 2nd quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company's stock valued at $34,000 after buying an additional 142 shares during the period. Salomon & Ludwin LLC acquired a new stake in shares of Itron during the 3rd quarter worth approximately $42,000. Wayfinding Financial LLC purchased a new stake in shares of Itron during the 1st quarter valued at approximately $45,000. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in Itron by 343.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company's stock valued at $46,000 after acquiring an additional 268 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company's stock.

Itron Company Profile

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

See Also

Analyst Recommendations for Itron (NASDAQ:ITRI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Itron Right Now?

Before you consider Itron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.

While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.